ProPhase Labs, Inc. (PRPH)
OTCMKTS · Delayed Price · Currency is USD
0.1495
+0.0145 (10.74%)
At close: May 4, 2026
ProPhase Labs Market Cap
ProPhase Labs has a market cap or net worth of $1.42 million as of May 5, 2026. Its market cap has decreased by -88.21% in one year.
Market Cap
1.42M
Enterprise Value
9.95M
Revenue
4.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.15
Market Cap Chart
Since January 2, 1996, ProPhase Labs's market cap has decreased from 5.04M to 1.42M, a decrease of -71.79%. That is a compound annual growth rate of -4.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 1.42M | -31.16% |
| Dec 31, 2025 | 2.07M | -88.57% |
| Dec 31, 2024 | 18.08M | -77.84% |
| Dec 29, 2023 | 81.56M | -47.97% |
| Dec 30, 2022 | 156.75M | 41.18% |
| Dec 31, 2021 | 111.03M | 4.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aspira Women's Health | 16.95M |
| Longduoduo Company | 15.31M |
| Psychemedics | 13.46M |
| iMD Companies | 5.42M |
| Stella Diagnostics | 4.22M |
| Centogene | 3.58M |
| Hypha Labs | 2.72M |
| InVitro International | 1.97M |